Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$13.17 - $16.4 $790,805 - $984,754
-60,046 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$16.3 - $17.26 $76,463 - $80,966
4,691 Added 8.47%
60,046 $984,000
Q2 2021

Aug 03, 2021

BUY
$16.55 - $18.64 $395,230 - $445,141
23,881 Added 75.88%
55,355 $932,000
Q1 2021

May 03, 2021

BUY
$16.71 - $19.9 $264,652 - $315,176
15,838 Added 101.29%
31,474 $528,000
Q4 2020

Feb 01, 2021

BUY
$15.39 - $18.97 $240,638 - $296,614
15,636 New
15,636 $285,000
Q3 2019

Nov 14, 2019

SELL
$16.15 - $17.99 $33,721 - $37,563
-2,088 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$16.58 - $20.49 $3,780 - $4,671
-228 Reduced 9.84%
2,088 $35,000
Q1 2019

May 09, 2019

BUY
$16.7 - $21.52 $37,324 - $48,097
2,235 Added 2759.26%
2,316 $45,000
Q4 2018

Jan 25, 2019

BUY
$15.64 - $21.1 $1,266 - $1,709
81 New
81 $1,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.